GALR2
MOLECULAR TARGETgalanin receptor 2
GALR2 (galanin receptor 2) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GALR2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | bdb gal 1 13 std i | 1.39 | 3 |
| 2 | Astemizole Antihistamine drug now withdrawn from | 1.10 | 2 |
About GALR2 as a Drug Target
GALR2 (galanin receptor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented GALR2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GALR2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.